Global Health Analytics, LLC (GHA) is a small, woman-owned company specializing in clinical trial design and analysis. With nearly 20 years of experience in trials evaluating vaccines, drugs, and devices, GHA provides strategic consultative support in areas including power and sample size calculations; study design; protocol development; Data Monitoring Committee membership and support; establishing go/no-go criteria for product advancement; and analysis of safety, immunogenicity, and efficacy data. GHA also has extensive experience in program evaluation (e.g., PEPFAR), epidemiology, pre-clinical trials, and other non-clinical research.